Fedele Dono Selected Research

Fedele Dono Research Topics

Disease

7	Epilepsy (Aura) 12/2023 - 01/2021
4	Status Epilepticus (Complex Partial Status Epilepticus) 02/2024 - 03/2021
3	Neoplasms (Cancer) 04/2024 - 11/2019
3	Brain Neoplasms (Brain Tumor) 02/2024 - 01/2021
3	COVID-19 08/2022 - 04/2021
2	Encephalitis (Encephalitis, Rasmussen) 04/2024 - 01/2022
2	Glioma (Gliomas) 02/2024 - 02/2024
2	Stroke (Strokes) 02/2024 - 11/2019
2	Neuroinflammatory Diseases 01/2023 - 10/2021
2	Sudden Unexpected Death in Epilepsy 01/2023 - 01/2022
2	Seizures (Absence Seizure) 08/2022 - 12/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 05/2022 - 01/2019
2	Headache (Headaches) 05/2022 - 02/2022
2	Migraine Disorders (Migraine) 02/2022 - 12/2021
2	Dementia (Dementias) 01/2022 - 12/2021
2	Delirium 01/2022 - 04/2021
1	Neurologic Manifestations (Neurological Manifestations) 04/2024
1	Premature Birth (Birth, Premature) 04/2024
1	Shock 02/2024
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2024
1	Wounds and Injuries (Trauma) 02/2024
1	Nervous System Diseases (Neurological Disorders) 12/2023
1	Down Syndrome (Down's Syndrome) 01/2023
1	Autoimmune Diseases of the Nervous System 01/2023
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2023
1	Brain Edema (Cerebral Edema) 11/2022
1	Intracranial Thrombosis (Cerebral Thrombosis) 11/2022
1	Temporal Lobe Epilepsy 07/2022
1	Thrombosis (Thrombus) 05/2022
1	Pain (Aches) 05/2022
1	Thrombocytopenia (Thrombopenia) 05/2022
1	Migraine without Aura (Common Migraine) 02/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 12/2021
1	Cognitive Dysfunction 01/2021
1	Inflammation (Inflammations) 09/2020
1	Multiple Sclerosis 11/2019
1	Ischemic Stroke 11/2019
1	Meningitis 01/2019
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2019
1	Synucleinopathies 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Drug Resistant Epilepsy 01/2018
1	MELAS Syndrome (Syndrome, MELAS) 01/2018

Drug/Important Bio-Agent (IBA)

7	perampanelIBA 12/2023 - 01/2021
3	AntibodiesIBA 01/2023 - 01/2022
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
3	VaccinesIBA 08/2022 - 02/2022
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2024 - 01/2022
2	SteroidsIBA 02/2024 - 09/2020
2	brivaracetamIBA 12/2023 - 03/2021
2	Lacosamide FDA Link 12/2023 - 01/2018
2	COVID-19 VaccinesIBA 11/2022 - 08/2022
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 01/2021
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2024
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2024
1	Prednisone (Sone)FDA LinkGeneric 02/2024
1	eslicarbazepine acetateIBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	AntigensIBA 01/2023
1	BenzodiazepinesIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Caffeine (No Doz)FDA LinkGeneric 08/2022
1	Vitamin K FDA Link 05/2022
1	Heparin (Liquaemin)FDA LinkGeneric 05/2022
1	Ad26COVS1IBA 05/2022
1	Platelet Factor 4IBA 05/2022
1	BNT162 VaccineIBA 02/2022
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022
1	thiocolchicosideIBA 01/2022
1	Enoxaparin (Lovenox)FDA LinkGeneric 04/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 04/2021
1	C-Reactive ProteinIBA 04/2021
1	Sodium Glutamate (Accent)IBA 11/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019

Therapy/Procedure

6	Therapeutics 02/2024 - 01/2019
3	Immunotherapy 04/2024 - 02/2024
1	Cesarean Section (Caesarean Section) 04/2024
1	Drug Therapy (Chemotherapy) 02/2024
1	Precision Medicine 02/2024
1	Spinal Injections 01/2022
1	Length of Stay 04/2021
1	Contraindications 01/2019